Palbociclib in combination with aromatase inhibitors in patients ≥ 75 years with oestrogen receptor-positive, human epidermal growth factor receptor 2 negative advanced breast cancer : a real-world multicentre UK study

El Badri, S., Tahir, B., Balachandran, K. et al. (18 more authors) (2021) Palbociclib in combination with aromatase inhibitors in patients ≥ 75 years with oestrogen receptor-positive, human epidermal growth factor receptor 2 negative advanced breast cancer : a real-world multicentre UK study. The Breast, 60. pp. 199-205. ISSN 0960-9776

Abstract

Metadata

Authors/Creators:
  • El Badri, S.
  • Tahir, B.
  • Balachandran, K.
  • Bezecny, P.
  • Britton, F.
  • Davies, M.
  • Desouza, K.
  • Dixon, S.
  • Hills, D.
  • Moe, M.
  • Pigott, T.
  • Proctor, A.
  • Shah, Y.
  • Simcock, R.
  • Stansfeld, A.
  • Synowiec, A.
  • Theodoulou, M.
  • Verrill, M.
  • Wadhawan, A.
  • Harper-Wynne, C.
  • Wilson, C.
Copyright, Publisher and Additional Information: © 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Keywords: Palbociclib; Breast cancer; Real-world; Frail elderly; Toxicity; Treatment efficacy; Cost analysis
Dates:
  • Accepted: 28 October 2021
  • Published (online): 28 October 2021
  • Published: December 2021
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 12 Nov 2021 07:13
Last Modified: 12 Nov 2021 07:13
Status: Published
Publisher: Elsevier BV
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.breast.2021.10.010

Share / Export

Statistics